The 17 references in paper A. Spasov A., I. Iejitsa N., M. Haritonova V., M. Kravchenco S., G. Snigur L., V. Pisarev B., А. Спасов А., И. Иежица Н., М. Харитонова В., М. Кравченко С., Г. Снигур Л., В. Писарев Б. (2008) “ЭКСПЕРИМЕНТАЛЬНОЕ ОБОСНОВАНИЕ ЭФФЕКТИВНОСТИ СОЛЕЙ МАГНИЯ В КОРРЕКЦИИ ЭКСПЕРИМЕНТАЛЬНОГО КАЛЬЦИЙ­ ФОСФАТНОГО НЕФРОЛИТИАЗА // THE EXPERIMENTAL BASIS FOR THE EFFICIENCY OF MAGNESIUM SALTS IN THE CORRECTION OF THE EXPERIMENTAL CALCIUM-PHOSPHATE NEPHROLITHIASIS” / spz:neicon:nefr:y:2008:i:3:p:72-78

1
Coe FL, Evan A, Worcester E. Kidney stone disease. J Clin Invest 2005; 115 (10): 2598-2608
(check this in PDF content)
2
Meyer JL, Smith LH. Epitaxial relationships in urolithiasis. The cacium oxalate monohydrate-hydroxiapatite system. Clin Sci Mol Med 1975; 49: 369-374
(check this in PDF content)
3
Ohman S, Laraaon L, Tiselius HG. Clinical significance of phosphate in calcium oxalate renal stones. Ann Clin Biochem 1992; 29 (1) : 59-63
(check this in PDF content)
4
Schmiedl A, Schwille PO. Magnesium status in idiopathic calcium urolithiasis-an orientational study in younger males. Eur J Clin Chem Clin Biochem 1996; 34 (5): 393-400
(check this in PDF content)
5
Hubbell RB, Mendel LB, Wakeman AJ. A salt mixture for use in experimental diets. J Nutr 1937; 14: 273-285
(check this in PDF content)
6
Parmar NS, Prakash S. Screening Methods in pharmacology, Alpha science International Ltd. Oxford, U.K. 2006; 256-263
(check this in PDF content)
7
Меньшиков ВВ, Делекторская ЛН, Золотнинская РМ. Лабораторные методы исследования в клинике: справоч­ ник. Медицина, М., 1987; 266-267
(check this in PDF content)
8
Сивориновский ГА. Количественное определение ща­ велевой кислоты в моче. Лаб дело 1969; (7): 401-404
(check this in PDF content)
9
AllegraA, Corica F, Ientile R etal. Plasma (total and ionized), erythrocyte and platelet magnesium levels in renal transplantant recipients during cyclosporine and/or azathioprine treatment. Magnes Res 1998; 11 (1): 11-18
(check this in PDF content)
10
Garsia-Rodrigeuez MB, Peres-Garsia CC, Rios- Granja MA et al. Renal handling of calcium and phosphorus in experimental renal hyperparathyroidism in dogs. Vet Res 2003; 34: 79-387
(check this in PDF content)
11
Рыбина ИЛ, ВощулаВИ. Оценка роли метаболизма оксалата в этиопатогенезе мочекаменной болезни. БМЖ 2006; (1): 15-19
(check this in PDF content)
12
Ritchie G, Kerstan1 D, Dai 1 L-Jun. 1,25(OH)2D3 stimulates Mg2+ uptake into MDCT cells: modulation by extracellular Ca2+ and Mg2+. Am J Physiol Renal Physiol 2001; 280: F868-F878
(check this in PDF content)
13
Murayama T, Sakai N, Takano T, Yamada T. Role of the urinary calcium in the growth of calcium stone. Hinyokika Kiyo 2004; 50 (7): 451-455
(check this in PDF content)
14
Bisaz S, Felix R, Neuman NM, Fleisch H. Quantitative determination of inhibitors of calcium phosphate precipitation in whole urine. Min Electrolyte Metab 1978; 1: 75-78
(check this in PDF content)
15
IezhitsaIN, SpasovAA, Kravchenko MS et al. Comparative study of magnesium salts’ bioavailability in rats fed with magnesium-deficient diet. J Japan Soc Magnes Res 2006; 25 (2): 99(153)
(check this in PDF content)
16
Firoz M, Graber M. Bioavailability of US commertial preparations. Magnes Res 2001; 14 (4): 257-262
(check this in PDF content)
17
Addadi L, Weiner S. Interactions between acidic proteins and crystals: stereochemical requirements in biomineralization. Proc Natl Acad Sci USA 1985; 82 (12): 4110­ 4114 Поступила в редакцию 10.03.2008 г.
(check this in PDF content)